Recent Press Releases

New study on TB vaccine for newborns of HIV-positive mothers

New study on TB vaccine for newborns of HIV-positive mothers 10 December 2012 UCT's South African Tuberculosis Vaccine Initiative (SATVI) and Stellenbosch's Desmond Tutu TB Centre have begun...

More than 30 million girls to be immunised with HPV vaccines by 2020 with GAVI support

More than 30 million girls to be immunised with HPV vaccines by 2020 with GAVI support Cancer vaccine targets leading cause of cancer death among women in GAVI-supported countries Dar Es...

Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec™ from Pfizer

Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec™ from Pfizer December 10, 2012 02:00 AM Eastern Time EXTON, Pa.--Nuron Biotech Inc., a specialty biologics and vaccines company,...

Sanofi Pasteur Launches IMOJEV® First Single-dose Vaccine Against Japanese Encephalitis in Australia

Sanofi Pasteur Launches IMOJEV® First Single-dose Vaccine Against Japanese Encephalitis in Australia MELBOURNE, Australia, December 9, 2012 - About 3 billion people living in Asia Pacific and...

Medicago Receives Support from the Government of Canada for Influenza Vaccine Programs

Medicago Receives Support from the Government of Canada for Influenza Vaccine Programs QUEBEC CITY, Dec. 11, 2012 -- Medicago Inc. (TSX: MDG) (OTCQX: MDCGF), a biopharmaceutical company focused on...

BiondVax's universal influenza vaccine M-001 significantly enhances the efficacy of the human pandemic H5N1 bird flu vaccine

BiondVax's universal influenza vaccine M-001 significantly enhances the efficacy of the human pandemic H5N1 bird flu vaccine Administration of M-001 before H5N1 avian influenza vaccine...

GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique

GSK forms partnership with Vodafone to help increase childhood vaccination in Mozambique Issued: Monday 10 December 2012, London, UK Partnership aims to create sustainable and scalable model to be...

Vical Licenses Vaxfectin(R) Adjuvant to Cyvax for Use in Malaria Vaccines

Vical Licenses Vaxfectin(R) Adjuvant to Cyvax for Use in Malaria Vaccines SAN DIEGO, Dec. 5, 2012 -- Vical Incorporated (Nasdaq:VICL) announced today a worldwide, nonexclusive license of its...

Fraunhofer USA Center for Molecular Biotechnology awarded NIH contract for "Vaccine Technologies to Advance Next Generation Anthrax Vaccines"

Fraunhofer USA Center for Molecular Biotechnology awarded NIH contract for "Vaccine Technologies to Advance Next Generation Anthrax Vaccines" NEWARK, Del.--Fraunhofer Center for Molecular...

Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate

Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate ROCKVILLE, Md., Dec. 3, 2012 -- Novavax, Inc. (Nasdaq:NVAX) today announced that the journal PLOS ONE...

National Institute of Health Awards Contract to Support Use of iBio's Proprietary Technology for Improved Anthrax Vaccine

National Institute of Health Awards Contract to Support Use of iBio's Proprietary Technology for Improved Anthrax Vaccine NEWARK, Del., Dec. 5, 2012-- iBio, Inc. (NYSE MKT: IBIO) announced...

Protein Sciences Corporation Expands Manufacturing Operations to Pearl River, New York

Protein Sciences Corporation Expands Manufacturing Operations to Pearl River, New York Company also looking to expand in Connecticut MERIDEN, Conn., Nov. 30, 2012 -- Protein Sciences Corporation,...

Altravax, Inc. Awarded $3.45 Million in NIH Funds for Vaccines to HIV/AIDS

Altravax, Inc. Awarded $3.45 Million in NIH Funds for Vaccines to HIV/AIDS MolecularBreeding(TM) technology platform offers new approach to vaccines FARGO, N.D. & SUNNYVALE, Calif., Dec 03, 2012...

Aldevron announces cancer vaccine manufacturing agreement with CureLab Oncology

Aldevron announces cancer vaccine manufacturing agreement with CureLab Oncology CureLab Oncology selects Aldevron to produce DNA-based vaccine for cancer treatment December 4, 2012. Aldevron (Fargo,...

Sanofi Pasteur Canada receives Health Canada Approval of Menactra® Meningococcal Conjugate Vaccine Indication for Infants starting at 9 months

Sanofi Pasteur Canada receives Health Canada Approval of Menactra® Meningococcal Conjugate Vaccine Indication for Infants starting at 9 months TORONTO, Dec. 3, 2012 Indication Provides Earlier...

Pollen: Can Humans' Seasonal Bane Become a Tool in the Fight Against Disease?

Pollen: Can Humans' Seasonal Bane Become a Tool in the Fight Against Disease? November 27, 2012 DARPA Young Faculty Award researcher studies use of pollen shells for oral delivery of vaccines As a...

Man's best friend: Common canine virus may lead to new vaccines for deadly human diseases

Man's best friend: Common canine virus may lead to new vaccines for deadly human diseases Athens, Ga. - Researchers at the University of Georgia have discovered that a virus commonly found in dogs...

Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies

Selecta Biosciences and Sanofi Sign Global Collaboration to Develop Antigen-Specific Immunotherapies for up to Three Allergy Indications Based on Selecta's Synthetic Vaccine Particle Technology...

A Single Dose Of Medicago's H5N1 VLP Vaccine Protects Against Additional Pandemic Flu Strains In A Preclinical Study

A Single Dose Of Medicago's H5N1 VLP Vaccine Protects Against Additional Pandemic Flu Strains In A Preclinical Study - First Demonstration of Cross-Protection Against H2N2 Influenza and a...

Novartis receives FDA approval for Flucelvax®, the first cell-culture vaccine in US to help protect against seasonal influenza

Novartis receives FDA approval for Flucelvax®, the first cell-culture vaccine in US to help protect against seasonal influenza Cell-culture technology, an alternative to traditional egg-based...